Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579702 · ClinicalTrials.gov registry record · NA
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
A NA study, sponsored by Insulet Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07579702 is a NA study that is actively recruiting participants, run by Insulet Corporation. The registered enrollment target is 200 participants.
The verdict
NCT07579702, a NA study, is actively recruiting participants, sponsored by Insulet Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
Interventions
- DEVICE Omnipod 5 System
- DEVICE Omnipod 6 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-05-13 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07579702
The ClinicalTrials.gov registry entry for NCT07579702 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omnipod 5 System is the first listed.
NCT07579702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07579702 about?
NCT07579702 is a clinical study titled "Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System". This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
What is the current status of trial NCT07579702?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-05-13. Estimated completion is 2027-02-01.
What interventions are being tested in trial NCT07579702?
The interventions under investigation include: Omnipod 5 System (DEVICE), Omnipod 6 System (DEVICE).
Who is sponsoring clinical trial NCT07579702?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.